Functional CB1 cannabinoid receptors in human vascular endothelial cells.
about
N-arachidonoyl L-serine, an endocannabinoid-like brain constituent with vasodilatory propertiesFatty acid amide hydrolase is a key regulator of endocannabinoid-induced myocardial tissue injuryThe endocannabinoid system as an emerging target of pharmacotherapyA biosynthetic pathway for anandamideVascular targets for cannabinoids: animal and human studiesTriphasic blood pressure responses to cannabinoids: do we understand the mechanism?The endocannabinoid/endovanilloid N-arachidonoyl dopamine (NADA) and synthetic cannabinoid WIN55,212-2 abate the inflammatory activation of human endothelial cellsInvolvement of cannabinoids in the cardioprotection induced by lipopolysaccharideAnandamide-induced relaxation of sheep coronary arteries: the role of the vascular endothelium, arachidonic acid metabolites and potassium channelsCannabinoid-receptor-independent cell signalling by N-acylethanolaminesCannabis exposure as an interactive cardiovascular risk factor and accelerant of organismal ageing: a longitudinal studyAnandamide elicits an acute release of nitric oxide through endothelial TRPV1 receptor activation in the rat arterial mesenteric bedNeuropharmacology of the endocannabinoid signaling system-molecular mechanisms, biological actions and synaptic plasticity.CB1 cannabinoid receptors increase neuronal precursor proliferation through AKT/glycogen synthase kinase-3beta/beta-catenin signalingThe Therapeutic Aspects of the Endocannabinoid System (ECS) for Cancer and their Development: From Nature to Laboratory.Activation of the Nlrp3 inflammasome in infiltrating macrophages by endocannabinoids mediates beta cell loss in type 2 diabetes.Peripheral CB1 cannabinoid receptor blockade improves cardiometabolic risk in mouse models of obesity.Cannabinoid-1 receptor activation induces reactive oxygen species-dependent and -independent mitogen-activated protein kinase activation and cell death in human coronary artery endothelial cells.Regulation of endocannabinoid release by G proteins: a paracrine mechanism of G protein-coupled receptor action.Endocannabinoid signaling via cannabinoid receptor 1 is involved in ethanol preference and its age-dependent decline in mice.Beneficial metabolic effects of CB1R anti-sense oligonucleotide treatment in diet-induced obese AKR/J mice.Endocannabinoids and neuroprotection.Cannabinoid-2 receptor agonist HU-308 protects against hepatic ischemia/reperfusion injury by attenuating oxidative stress, inflammatory response, and apoptosisCannabinoids and cancer: pros and cons of an antitumour strategy.CB(1) cannabinoid receptors and their associated proteins.Cannabinoid pharmacology in the cardiovascular system: potential protective mechanisms through lipid signalling.Cannabinoid 1 receptor promotes cardiac dysfunction, oxidative stress, inflammation, and fibrosis in diabetic cardiomyopathyA synergistic interaction of 17-β-estradiol with specific cannabinoid receptor type 2 antagonist/inverse agonist on proliferation activity in primary human osteoblasts.Cannabidiol causes endothelium-dependent vasorelaxation of human mesenteric arteries via CB1 activationCannabinoids as therapeutic agents in cardiovascular disease: a tale of passions and illusionsCannabinoid Receptor Type 2 (CB2) Dependent and Independent Effects of WIN55,212-2 on Atherosclerosis in Ldlr-null Mice.Blood pressure regulation by endocannabinoids and their receptorsMice lacking GPR3 receptors display late-onset obese phenotype due to impaired thermogenic function in brown adipose tissueEndocannabinoids and liver disease--review.Progesterone-dependent regulation of endometrial cannabinoid receptor type 1 (CB1-R) expression is disrupted in women with endometriosis and in isolated stromal cells exposed to 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD).Hepatic cannabinoid receptor-1 mediates diet-induced insulin resistance via inhibition of insulin signaling and clearance in mice.Endocannabinoids and cannabinoid receptors in ischaemia-reperfusion injury and preconditioningCannabinoid receptors and the regulation of bone mass.Cannabidiol inhibits angiogenesis by multiple mechanisms.Decreased age-related cardiac dysfunction, myocardial nitrative stress, inflammatory gene expression, and apoptosis in mice lacking fatty acid amide hydrolase.
P2860
Q24541462-53624599-95D0-496F-8726-49D3791063EEQ24595633-F466C76D-DCA3-4C3A-BCEA-693A2066CF3DQ24648473-52E7D81B-201D-4FB1-96D1-E08ADCC5142CQ24671032-8197BE6C-3C8D-4D91-BFE2-E0C4798EF0BDQ26862515-6ECAE5FB-8C58-4E53-ABFC-A196DE2FEBE7Q27025612-A38B55C9-5B5C-4D6D-9C07-385171592ADFQ28236199-054DB1D4-DB78-4F12-9D80-51653815B535Q28349586-F166C9AA-BADA-4886-9FD1-C5ADB901B233Q28362724-D541CDDB-F3FF-494B-BC1C-A14B92B5067DQ28363293-42C3A70F-7697-4733-9894-109E3B83F635Q28395270-5321D463-4DC1-44C5-85FC-07A082B69DECQ28579681-23B5A15C-4DA4-4868-8654-2C36374AB035Q30493991-30101AF5-8B6F-45AB-93EF-CCB5346EA9BFQ33524983-7E9E37A7-75D3-4839-9750-64C704DE378AQ33623423-83F46AB6-B02F-4846-9372-331AD7045F0EQ33731729-56E484FF-24F1-4F07-B451-77D269E9D299Q34028741-C88752A7-A40A-47BE-B653-658D885375D1Q34098271-4F58F0DF-66E1-4488-A104-C20EE3968A6EQ34214049-818427B5-3C9E-4391-90C9-1E46A08867E7Q34331157-0161C523-9BB7-49B5-AC47-BC41F702DDFFQ34369293-7BE44239-355B-4BF3-8FE7-039AEEFFA7CAQ34611968-AFF3CA5A-22B1-4705-AE28-261A2741D23DQ34655802-4FDDE48B-21D4-486A-A451-EE4B68109D7FQ35100892-7E99905A-00D4-4EE2-963B-5E80A0455C7BQ35232109-D660C13E-B934-468D-9855-8CF9C44A8A24Q35684044-975A8358-4E91-4C54-B119-CF3912E04492Q35766956-C10908F9-6D50-48EE-9FAD-A6C5507BCD8FQ35803402-36E56272-F997-4AD1-B6F9-DC3A3F732EF7Q35966006-A5EFE94E-A486-4CAA-B887-5284DEB6E70EQ36052772-79882065-E00E-4CD7-9D3C-2931ACE4F023Q36089227-0C17C74E-8592-418C-A8BA-26AB810D0415Q36135785-E9310E4C-BB5D-4A1C-A768-1B52CA943186Q36146799-6B5E820C-0557-4BC1-8513-4598F611CB2DQ36257249-50C4E2E2-3A4D-49F5-B2CC-7FB5777B7FC2Q36291274-F19B5AEF-2FB9-4EF4-9AF2-32E5EA64385CQ36351511-33DF2092-1DE7-4658-A773-2881C4291254Q36416372-DA51D4EE-84F7-45B4-B4D0-6215ABBA3FF8Q36416382-141365B6-D35A-4850-82E5-3B6637786425Q36419293-BA1656DB-2807-432E-9BBB-495A2D61542CQ36426806-12D2D0A7-1BDE-4976-8658-FE820AE832E4
P2860
Functional CB1 cannabinoid receptors in human vascular endothelial cells.
description
2000 nî lūn-bûn
@nan
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
2000年论文
@zh
2000年论文
@zh-cn
name
Functional CB1 cannabinoid receptors in human vascular endothelial cells.
@en
type
label
Functional CB1 cannabinoid receptors in human vascular endothelial cells.
@en
prefLabel
Functional CB1 cannabinoid receptors in human vascular endothelial cells.
@en
P2093
P2860
P921
P1433
P1476
Functional CB1 cannabinoid receptors in human vascular endothelial cells.
@en
P2093
P2860
P304
P356
10.1042/0264-6021:3460835
P407
P478
P577
2000-03-01T00:00:00Z